When was SimplicityBio founded?

SimplicityBio was founded in 2013 and raised its 1st funding round 2 years after it was founded.

Where is SimplicityBio located?

SimplicityBio is headquartered in Monthey, Switzerland.

How many employees does SimplicityBio have?

As of Jul 01, 2024, the latest employee count at SimplicityBio is 1.

Is SimplicityBio a funded company?

SimplicityBio is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on 2015.

When was the latest funding round of SimplicityBio?

SimplicityBio's latest funding was a $***** Seed round on 2015, with participation from 1 investor.

Where does SimplicityBio rank among its competitors?

SimplicityBio ranks 566th amongst 1568 active competitors, of which 207 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Hublo, which secured $47.3M in Feb, 2026.

Who are the top competitors of SimplicityBio?

SimplicityBio's top competitors include IQVIA, Strand Life Sciences and Benchling. Among them, Hublo secured the most recent funding round in February, 2026.

SimplicityBio - 2026 Company Profile, Team, Funding & Competitors

Company Details

SimplicityBio is a biomarker discovery company which provides in-silico solutions for bioinformatics. Services include in-silico biomarker discovery and biomarker ranking, signature creation (biomarkers + classification algorithm) and improvement of an existent signature (sensitivity, specificity and robustness). It identifies biomarkers which can be used for diagnostics, patient stratification, follow-up or treatment response of certain diseases. As molecular diagnostic tests must reach certain sensitivity and specificity thresholds set by regulatory bodies in order to reach the market (e.g. CE IVD mark, FDA approval), its technology can be used for signature creation and improvement.

Website: simplicitybio.com
Social

Key Metrics

Founded Year

2013

Location

Monthey, Switzerland

Stage

Acquired

Total Funding

$30.3K in 1 round

Latest Funding Round

Seed, 2015, $*****

Investors

Venture Kick & 6 more

Ranked

566^th among 1568 active competitors

Employee Count

1 as on Jul 01, 2024

Similar Companies

IQVIA & 2194 more

Exit Details

Acquired by Precision Medicine Group (Mar 06, 2019)

View SimplicityBio's full profile

SimplicityBio got acquired by Precision Medicine Group on Mar 06, 2019.

Click here to take a look at SimplicityBio's acquisition in detail

SimplicityBio has raised a total funding of $30.3K over 1 round. Its latest funding round was a Seed round on 2015 for $*****. 1 investor participated in its latest round. SimplicityBio has 7 institutional investors.

Here is the list of recent funding rounds of SimplicityBio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2015	4280	Seed	5721	9798	3410	9788

Access funding benchmarks and valuations. Sign up today!

View details of SimplicityBio's funding rounds and investors

The founders of SimplicityBio is Pedro Faustino.

Here are the details of SimplicityBio's key team members:

Pedro Faustino: COO and co-founder of SimplicityBio.

View details of SimplicityBio's Founder profiles and Board Members

SimplicityBio's employee count trend

SimplicityBio has 1 employees as of Jul 24. Here is SimplicityBio's employee count trend over the years:

Uncover SimplicityBio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SimplicityBio include IQVIA, Strand Life Sciences and Benchling. Here is the list of Top 10 competitors of SimplicityBio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Aisling Capital ... & 12 others	80/100
2nd	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, WestBridge Capital & 92 others	74/100
3rd	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Benchmark & 29 others	73/100
4th	Hublo 2013, Montreuil (France), Series C	Workforce management and staffing platform designed for healthcare and social care institutions	$97.9M	Acton Capital, Y Combinator & 5 others	72/100
5th	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
6th	AVIA 2003, Chicago (United States), Series B	Digital business management and networking platform for the healthcare industry	$50M	Providence, MemorialCare Innovation Fund ... & 20 others	68/100
7th	Cellworks 2005, San Jose (United States), Series B	Developer of a biosimulation platform	$16.5M	Bering Capital, Artiman & 3 others	66/100
8th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
9th	Saama 1999, Campbell (United States), Series C	AI-enabled platofrm for clinical trial data analytics	$75.8M	Perceptive Advisors, Northpond Ventures & 10 others	64/100
10th	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 24 others	62/100
566th	SimplicityBio 2013, Monthey (Switzerland), Acquired	In-silico solutions for bioinformatics	$30.3K	MassChallenge, Swiss ICT Investor Club & 5 others	26/100